Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Non-Current Assets (2016 - 2025)

Collegium Pharmaceutical has reported Non-Current Assets over the past 10 years, most recently at $965.4 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $965.4 million for Q4 2025, down 18.28% from a year ago — trailing twelve months through Dec 2025 was $4.1 billion (up 17.63% YoY), and the annual figure for FY2025 was $965.4 million, down 18.28%.
  • Non-Current Assets for Q4 2025 was $965.4 million at Collegium Pharmaceutical, down from $993.5 million in the prior quarter.
  • Over the last five years, Non-Current Assets for COLL hit a ceiling of $1.2 billion in Q3 2024 and a floor of $349.8 million in Q1 2021.
  • Median Non-Current Assets over the past 5 years was $735.1 million (2022), compared with a mean of $750.2 million.
  • Biggest five-year swings in Non-Current Assets: surged 152.32% in 2022 and later fell 19.72% in 2024.
  • Collegium Pharmaceutical's Non-Current Assets stood at $376.5 million in 2021, then soared by 100.29% to $754.1 million in 2022, then decreased by 19.68% to $605.7 million in 2023, then soared by 95.03% to $1.2 billion in 2024, then fell by 18.28% to $965.4 million in 2025.
  • The last three reported values for Non-Current Assets were $965.4 million (Q4 2025), $993.5 million (Q3 2025), and $1.0 billion (Q2 2025) per Business Quant data.